Series B Investors & VC Firms in France
83 firms in this list, with a median first check of $587.5K. 4 of them lead rounds. Generated from verified public data and updated continuously.
Starquest Capital
ParisSeed–Series B$1.1M – $10.8M
7 people
Motier Ventures
ParisPre-Seed–Series B$330K – $3.3M
BioMedPartners
BaselSeed–Late Stage$648K – $6.5M
6 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Series B$16.2M
9 people
Anterra Capital
AmsterdamSeed–Late Stage$20M
8 people
115K
ParisSeed–Series B$270K – $5.4M
5 people
AMR Action Fund
BostonSeed–Series B
8 people
Clay Capital
Seed–Late Stage$3M – $8M
5 people
Debiopharm Innovation Fund
LausanneSeries A–Late Stage$3M – $5M
5 people
Orange Digital Ventures
Issy-les-MoulineauxSeed–Late Stage
7 people
Forepont Capital Partners
New YorkSeed–Late Stage
7 people
German Media Pool
BerlinSeed–Late Stage$540K – $5.4M
4 people
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $10.8M
4 people
The Finnish Innovation Fund Sitra
HelsinkiSeed–Late Stage$108K
4 people
Tioga Capital Partners
BrusselsPre-Seed–Series B$540K – $5.4M
4 people
Wa'ed Ventures
DhahranSeed–Series B$20M
7 people
Frst
ParisSeed–Series B$540K – $5.4M
3 people
Aster Capital
ParisSeed–Series B$540K – $16.2M
3 people
CITA Investissement
ParisSeed–Late Stage$1.1M – $16.2M
3 people
GET Fund
MunichSeries A–Late Stage
6 people
Piton Capital LLP
LondonSeed–Late Stage$254K – $25.4M
3 people
Bpifrance
ParisSeed–Late Stage$270K
2 people
Safran Corporate Ventures
ParisSeed–Series B$1.1M – $5.4M
2 people
French Partners
ParisSeed–Series B$1.1M – $5.4M
1 person
Related lists
Seed Investors & VC Firms (7051)Series A Investors & VC Firms (4959)Investors & VC Firms in United States (2654)Series B Investors & VC Firms (2615)Pre-Seed Investors & VC Firms (2349)Late Stage Investors & VC Firms (2244)Seed Investors & VC Firms in United States (2211)Series A Investors & VC Firms in United States (2107)Growth Investors & VC Firms (1963)Series C Investors & VC Firms (1701)
Data sourced from public filings and firms' own websites — see our methodology.